Eriseld Krasniqi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Cancer science

International journal of molecular sciences

Cancers

Medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Claudio Botti, Fabio Pelle, Flavia Cavicchi, Sonia Cappelli, Maddalena Barba, Laura Pizzuti, Marcello Maugeri-Saccà, Luca Moscetti, Antonino Grassadonia, Nicola Tinari, Giuseppe Sanguineti, Silvia Takanen, Davide Fragnito, Irene Terrenato, Simonetta Buglioni, Letizia Perracchio, Agnese Latorre, Ruggero De Maria, Matteo Pallocca, Gennaro Ciliberto, Francesco Giotta, Patrizia Vici
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study. Cancers 16 (15) (2024)
Giulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Beatrice Messina, Giulia Schiavoni, Giuseppe Sanguineti, Claudio Botti, Sonia Cappelli, Fabio Pelle, Flavia Cavicchi, Ilaria Puccica, Maurizio Costantini, Letizia Perracchio, Marcello Maugeri-Saccà, Gennaro Ciliberto, Patrizia Vici
HER2 mutation as an emerging target in advanced breast cancer. Cancer science 115 (7) (2024)
Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Claudio Botti, Fabio Pelle, Flavia Cavicchi, Sonia Cappelli, Maddalena Barba, Laura Pizzuti, Marcello Maugeri-Saccà, Luca Moscetti, Antonino Grassadonia, Nicola Tinari, Giuseppe Sanguineti, Silvia Takanen, Davide Fragnito, Irene Terrenato, Simonetta Buglioni, Letizia Perracchio, Agnese Latorre, Ruggero De Maria, Matteo Pallocca, Gennaro Ciliberto, Francesco Giotta, Patrizia Vici
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study. Cancers 16 (15) (2024)
Giulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Beatrice Messina, Giulia Schiavoni, Giuseppe Sanguineti, Claudio Botti, Sonia Cappelli, Fabio Pelle, Flavia Cavicchi, Ilaria Puccica, Maurizio Costantini, Letizia Perracchio, Marcello Maugeri-Saccà, Gennaro Ciliberto, Patrizia Vici
HER2 mutation as an emerging target in advanced breast cancer. Cancer science 115 (7) (2024)
Giulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Beatrice Messina, Giulia Schiavoni, Giuseppe Sanguineti, Claudio Botti, Sonia Cappelli, Fabio Pelle, Flavia Cavicchi, Ilaria Puccica, Maurizio Costantini, Letizia Perracchio, Marcello Maugeri-Saccà, Gennaro Ciliberto, Patrizia Vici
HER2 mutation as an emerging target in advanced breast cancer. Cancer science 115 (7) (2024)
Giulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Beatrice Messina, Giulia Schiavoni, Giuseppe Sanguineti, Claudio Botti, Sonia Cappelli, Fabio Pelle, Flavia Cavicchi, Ilaria Puccica, Maurizio Costantini, Letizia Perracchio, Marcello Maugeri-Saccà, Gennaro Ciliberto, Patrizia Vici
HER2 mutation as an emerging target in advanced breast cancer. Cancer science 115 (7) (2024)
Giulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Beatrice Messina, Giulia Schiavoni, Giuseppe Sanguineti, Claudio Botti, Sonia Cappelli, Fabio Pelle, Flavia Cavicchi, Ilaria Puccica, Maurizio Costantini, Letizia Perracchio, Marcello Maugeri-Saccà, Gennaro Ciliberto, Patrizia Vici
HER2 mutation as an emerging target in advanced breast cancer. Cancer science (2024)
Giulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Beatrice Messina, Giulia Schiavoni, Giuseppe Sanguineti, Claudio Botti, Sonia Cappelli, Fabio Pelle, Flavia Cavicchi, Ilaria Puccica, Maurizio Costantini, Letizia Perracchio, Marcello Maugeri-Saccà, Gennaro Ciliberto, Patrizia Vici
HER2 mutation as an emerging target in advanced breast cancer. Cancer science 115 (7) (2024)
Eriseld Krasniqi, Frauke Goeman, Claudio Pulito, Alina Catalina Palcau, Ludovica Ciuffreda, Francesca Sofia Di Lisa, Lorena Filomeno, Maddalena Barba, Laura Pizzuti, Federico Cappuzzo, Giuseppe Sanguineti, Marcello Maugeri-Saccà, Gennaro Ciliberto, Maurizio Fanciulli, Giovanni Blandino, Patrizia Vici
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. International journal of molecular sciences 23 (23) (2022)
Eriseld Krasniqi, Frauke Goeman, Claudio Pulito, Alina Catalina Palcau, Ludovica Ciuffreda, Francesca Sofia Di Lisa, Lorena Filomeno, Maddalena Barba, Laura Pizzuti, Federico Cappuzzo, Giuseppe Sanguineti, Marcello Maugeri-Saccà, Gennaro Ciliberto, Maurizio Fanciulli, Giovanni Blandino, Patrizia Vici
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. International journal of molecular sciences 23 (23) (2022)
Eriseld Krasniqi, Frauke Goeman, Claudio Pulito, Alina Catalina Palcau, Ludovica Ciuffreda, Francesca Sofia Di Lisa, Lorena Filomeno, Maddalena Barba, Laura Pizzuti, Federico Cappuzzo, Giuseppe Sanguineti, Marcello Maugeri-Saccà, Gennaro Ciliberto, Maurizio Fanciulli, Giovanni Blandino, Patrizia Vici
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. International journal of molecular sciences 23 (23) (2022)
Eriseld Krasniqi, Frauke Goeman, Claudio Pulito, Alina Catalina Palcau, Ludovica Ciuffreda, Francesca Sofia Di Lisa, Lorena Filomeno, Maddalena Barba, Laura Pizzuti, Federico Cappuzzo, Giuseppe Sanguineti, Marcello Maugeri-Saccà, Gennaro Ciliberto, Maurizio Fanciulli, Giovanni Blandino, Patrizia Vici
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. International journal of molecular sciences 23 (23) (2022)
Eriseld Krasniqi, Frauke Goeman, Claudio Pulito, Alina Catalina Palcau, Ludovica Ciuffreda, Francesca Sofia Di Lisa, Lorena Filomeno, Maddalena Barba, Laura Pizzuti, Federico Cappuzzo, Giuseppe Sanguineti, Marcello Maugeri-Saccà, Gennaro Ciliberto, Maurizio Fanciulli, Giovanni Blandino, Patrizia Vici
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. International journal of molecular sciences 23 (23) (2022)
Maddalena Barba, Eriseld Krasniqi, Laura Pizzuti, Marco Mazzotta, Daniele Marinelli, Greta Giuliano, Francesca Sofia Di Liso, Federico Cappuzzo, Lorenza Landi, Silverio Tomao, Gennaro Ciliberto, Patrizia Vici
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience. The breast journal 27 (4) (2021)
Eriseld Krasniqi, Giacomo Barchiesi, Marco Mazzotta, Laura Pizzuti, Alice Villa, Maddalena Barba, Patrizia Vici
Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane. Medicine 99 (31) (2020)
Patrizia Vici, Laura Pizzuti, Eriseld Krasniqi, Andrea Botticelli, Gennaro Ciliberto, Maddalena Barba
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors. Immunotherapy 12 (10) (2020)
Laura Pizzuti, Eriseld Krasniqi, Giacomo Barchiesi, Marina Della Giulia, Fiorentino Izzo, Giuseppe Sanguineti, Paolo Marchetti, Marco Mazzotta, Raffaele Giusti, Andrea Botticelli, Teresa Gamucci, Clara Natoli, Antonino Grassadonia, Nicola Tinari, Laura Iezzi, Silverio Tomao, Federica Tomao, Giuseppe Tonini, Daniele Santini, Antonio Astone, Andrea Michelotti, Claudia De Angelis, Lucia Mentuccia, Angela Vaccaro, Emanuela Magnolfi, Alain Gelibter, Valentina Magri, Enrico Cortesi, Loretta D'Onofrio, Alessandra Cassano, Ernesto Rossi, Marina Cazzaniga, Luca Moscetti, Claudia Omarini, Federico Piacentini, Maria A Fabbri, Angelo F Scinto, Domenico Corsi, Luisa Carbognin, Emilio Bria, Nicla La Verde, Riccardo Samaritani, Carlo Garufi, Sandro Barni, Rosanna Mirabelli, Roberta Sarmiento, Enzo M Veltri, Giuliana D'Auria, Ida Paris, Francesco Giotta, Vito Lorusso, Franca Cardillo, Elisabetta Landucci, Maria Mauri, Corrado Ficorella, Mario Roselli, Vincenzo Adamo, Giuseppina R R Ricciardi, Antonio Russo, Rossana Berardi, Mirco Pistelli, Elena Fiorio, Katia Cannita, Valentina Sini, Nicola D'Ostilio, Jennifer Foglietta, Filippo Greco, Claudio Zamagni, Ornella Garrone, Barbara Di Cocco, Editta Baldini, Lorenzo Livi, Isacco Desideri, Icro Meattini, Giuseppina Sarobba, Pietro Del Medico, Michele De Tursi, Daniele Generali, Ruggero De Maria, Emanuela Risi, Gennaro Ciliberto, Isabella Sperduti, Alice Villa, Maddalena Barba, Angelo Di Leo, Patrizia Vici
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. International journal of cancer 146 (7) (2019)

Eriseld Krasniqi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eriseld Krasniqi